Pages that link to "Q80093411"
Jump to navigation
Jump to search
The following pages link to Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64 (Q80093411):
Displaying 37 items.
- Elemental labelling combined with liquid chromatography inductively coupled plasma mass spectrometry for quantification of biomolecules: a review (Q26824092) (← links)
- Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA (Q28741667) (← links)
- Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. (Q33301860) (← links)
- Non-cross-bridged tetraazamacrocyclic chelator for stable (64)cu-based radiopharmaceuticals (Q33636030) (← links)
- Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease (Q33870879) (← links)
- Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals (Q34119201) (← links)
- In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. (Q34519479) (← links)
- 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies (Q34665668) (← links)
- Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator (Q34677178) (← links)
- Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines (Q34778496) (← links)
- Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide (Q34870617) (← links)
- Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies (Q34992753) (← links)
- Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein (Q35537301) (← links)
- Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. (Q35713096) (← links)
- 64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistry (Q36060540) (← links)
- Synthesis, Cu(ii) complexation,64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms (Q36291655) (← links)
- Microfluidic radiolabeling of biomolecules with PET radiometals (Q36446048) (← links)
- 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer (Q36777374) (← links)
- New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging. (Q37104310) (← links)
- A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. (Q37172093) (← links)
- Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). (Q37356557) (← links)
- Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research (Q37478003) (← links)
- Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors (Q37479595) (← links)
- Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. (Q37545575) (← links)
- A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics. (Q37619943) (← links)
- Radiopharmaceutical development of radiolabelled peptides (Q37990399) (← links)
- Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals (Q38172069) (← links)
- Synthesis and radiolabeling of chelator–RNA aptamer bioconjugates with copper-64 for targeted molecular imaging (Q38334449) (← links)
- Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases (Q39565634) (← links)
- Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker (Q41612568) (← links)
- Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes (Q42084619) (← links)
- Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. (Q42165286) (← links)
- Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA. (Q43376047) (← links)
- Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments. (Q53676991) (← links)
- ImmunoPET: Concept, Design, and Applications (Q90581932) (← links)
- Synthesis and evaluation of 64Cu-radiolabeled NOTA-cetuximab (64Cu-NOTA-C225) for immuno-PET imaging of EGFR expression (Q92477543) (← links)
- Copper-Bispidine Complexes: Synthesis and Complex Stability Study (Q92925250) (← links)